These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1433893)

  • 21. [Fundamental and clinical studies of piperacillin in the field of obstetrics and gynecology].
    Ohtsuka T; Uemura T; Minaguchi H
    Jpn J Antibiot; 1982 Sep; 35(9):2200-5. PubMed ID: 6216353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of severe infection in patients with hematological disorders by cefminox. Tokai Infection Study Group].
    Okumura M; Ohno R; Mitomo Y; Hirano M; Shirakawa S; Yoshikawa S; Kobayashi M; Yamada K
    Jpn J Antibiot; 1985 Jun; 38(6):1619-24. PubMed ID: 3930807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transfer of beta-lactam preparations created in Japan to lung tissue and the drug selection for chemotherapy of respiratory tract infections.
    Imaizumi M; Ojika T; Sakakibara M; Kondo D; Watanabe H; Nishimura M; Abe T
    Drugs Exp Clin Res; 1992; 18(4):111-20. PubMed ID: 1451642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Serum and sputum levels of cefotetan used in respiratory tract infections].
    Matsumoto Y; Hitsuda Y; Sugimoto Y; Ishikawa J; Sasaki T
    Jpn J Antibiot; 1986 Oct; 39(10):2690-4. PubMed ID: 3468274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A study of transfer of cefbuperazone into postoperative exudates in patients with cancer mastectomy or thyroidectomy].
    Sasaki F; Takada N; Hata Y; Kyunoh K; Uchino J
    Jpn J Antibiot; 1988 Apr; 41(4):460-6. PubMed ID: 3404652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Excretion of antibiotics into bile and urine in patients with external cholecystostomy done in order to treat obstructive jaundice].
    Hidaka K; Yamamoto H; Harada S; Katano M; Fujiwara H; Mizoguchi T; Hisatsugu T; Yamaoka K; Kisu T
    Jpn J Antibiot; 1988 Sep; 41(9):1295-303. PubMed ID: 3241327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Basic and clinical studies on cefminox in the field of obstetrics and gynecology].
    Hirabayashi K; Okada E
    Jpn J Antibiot; 1985 May; 38(5):1304-10. PubMed ID: 3930801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefminox sodium penetration into prostatic tissue with and without inflammation.
    Sasagawa I; Yamaguchi O; Shiraiwa Y
    Int Urol Nephrol; 1991; 23(6):569-72. PubMed ID: 1722784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Basic and clinical studies on cefminox in the field of obstetrics and gynecology].
    Tanada S; Takashima E; Haruta T; Kobayashi Y
    Jpn J Antibiot; 1985 May; 38(5):1279-86. PubMed ID: 3930798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fundamental studies of transferred concentration of piperacillin into maternal serum, umbilical cord serum and amniotic fluid].
    Iwasaki T; Machihara M
    Jpn J Antibiot; 1982 Sep; 35(9):2206-12. PubMed ID: 6216354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Concentration of piperacillin in bone].
    Kato M; Morimoto R
    Jpn J Antibiot; 1984 Mar; 37(3):279-84. PubMed ID: 6737692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fundamental and clinical study on cefminox in the obstetrical and gynecological field].
    Takamura S
    Jpn J Antibiot; 1985 Aug; 38(8):2124-8. PubMed ID: 3935823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tissue distribution of cefminox in beagle dogs].
    Chiba F; Sakurai T; Nakayoshi T; Shinkai S; Fujita M; Komiya I
    Jpn J Antibiot; 1985 Jul; 38(7):1769-75. PubMed ID: 3934421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical study with piperacillin in the field of obstetrics and gynecology].
    Ikeda M; Noda K
    Jpn J Antibiot; 1982 Oct; 35(10):2348-53. PubMed ID: 6223153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical laboratory approach in estimating effective administrative dose of piperacillin. Reevaluation of MIC break points in 3 and 4 category systems of disc susceptibility test].
    Matsuo K; Uete T
    Jpn J Antibiot; 1990 Sep; 43(9):1559-71. PubMed ID: 2262963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Penetration of piperacillin-tazobactam into human prostate tissue and dosing considerations for prostatitis based on site-specific pharmacokinetics and pharmacodynamics.
    Kobayashi I; Ikawa K; Nakamura K; Nishikawa G; Kajikawa K; Yoshizawa T; Watanabe M; Kato Y; Zennami K; Kanao K; Tobiume M; Yamada Y; Mitsui K; Narushima M; Morikawa N; Sumitomo M
    J Infect Chemother; 2015 Aug; 21(8):575-80. PubMed ID: 26050020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical evaluation of piperacillin in the urological field].
    Hayashida S; Kitajima K; Joko K
    Hinyokika Kiyo; 1983 Apr; 29(4):465-76. PubMed ID: 6563846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Piperacillin concentration in the pelvic dead space exudate following surgery of cervical cancer].
    Koike K; Ohshima T
    Jpn J Antibiot; 1983 Oct; 36(10):2820-4. PubMed ID: 6674517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Basic and clinical studies on cefminox in the field of obstetrics and gynecology].
    Itoh K; Kondo H; Hayasaki M; Noda K
    Jpn J Antibiot; 1985 May; 38(5):1244-53. PubMed ID: 3930793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Basic and clinical studies on cefminox in the field of obstetrics and gynecology].
    Yamamoto T; Yasuda J; Tomioka M; Kanao M; Okada H
    Jpn J Antibiot; 1985 May; 38(5):1260-7. PubMed ID: 3930795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.